MTT and Blood-Brain Barrier Disruption within Asymptomatic Vascular WM Lesions

References

1. 1.↵
   2. Corriveau RA,
   3. Bosetti F,
   4. Emr M, et al

   . The science of vascular contributions to cognitive impairment and dementia (VCID): a framework for advancing research priorities in the cerebrovascular biology of cognitive decline. Cell Mol Neurobiol 2016;36:281–88 doi:10.1007/s10571-016-0334-7 pmid:27095366

   CrossRefPubMed
2. 2.↵
   2. Corriveau RA,
   3. Koroshetz WJ,
   4. Gladman JT, et al

   . Alzheimer's disease-related dementias summit 2016: national research priorities. Neurology 2017;89:2381–91 doi:10.1212/WNL.0000000000004717 pmid:29117955

   Abstract/FREE Full Text
3. 3.↵
   2. Bath PM,
   3. Wardlaw JM

   . Pharmacological treatment and prevention of cerebral small vessel disease: a review of potential interventions. Int J Stroke 2015;10:469–78 doi:10.1111/ijs.12466 pmid:25727737

   CrossRefPubMed
4. 4.↵
   2. Wardlaw JM,
   3. Smith C,
   4. Dichgans M

   . Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging. Lancet Neurol 2013;12:483–97 doi:10.1016/S1474-4422(13)70060-7 pmid:23602162

   CrossRefPubMedWeb of Science
5. 5.↵
   2. Edrissi H,
   3. Schock SC,
   4. Cadonic R, et al

   . Cilostazol reduces blood brain barrier dysfunction, white matter lesion formation and motor deficits following chronic cerebral hypoperfusion. Brain Res 2016;1646:494–503 doi:10.1016/j.brainres.2016.06.036 pmid:27350079

   CrossRefPubMed
6. 6.↵
   2. Wardlaw JM,
   3. Smith EE,
   4. Biessels GJ, et al

   . Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol 2013;12:822–38 doi:10.1016/S1474-4422(13)70124-8 pmid:23867200

   CrossRefPubMedWeb of Science
7. 7.↵
   2. Thrippleton MJ,
   3. Backes WH,
   4. Sourbron S, et al

   . Quantifying blood-brain barrier leakage in small vessel disease: review and consensus recommendations. Alzheimers Dement 2019;15:840–58 doi:10.1016/j.jalz.2019.01.013 pmid:31031101

   CrossRefPubMed
8. 8.↵
   2. Tsai CF,
   3. Thomas B,
   4. Sudlow CL

   . Epidemiology of stroke and its subtypes in Chinese vs white populations: a systematic review. Neurology 2013;81:264–72 doi:10.1212/WNL.0b013e31829bfde3 pmid:23858408

   Abstract/FREE Full Text
9. 9.↵
   2. Maillard P,
   3. Carmichael O,
   4. Fletcher E, et al

   . Coevolution of white matter hyperintensities and cognition in the elderly. Neurology 2012;79:442–48 doi:10.1212/WNL.0b013e3182617136 pmid:22815562

   Abstract/FREE Full Text
10. 10.↵
    2. Traylor M,
    3. Lewis CM

    . Genetic discovery in multi-ethnic populations. Eur J Hum Genet 2016;24:1097–98 doi:10.1038/ejhg.2016.38 pmid:27142679

    CrossRefPubMed
11. 11.↵
    2. Vermeer SE,
    3. Longstreth WT Jr.,
    4. Koudstaal PJ

    . Silent brain infarcts: a systematic review. Lancet. Neurol 2007;6:611–19 doi:10.1016/S1474-4422(07)70170-9 pmid:17582361

    CrossRefPubMedWeb of Science
12. 12.↵
    2. Li Y,
    3. Li M,
    4. Zuo L, et al

    . Compromised blood-brain barrier integrity is associated with total magnetic resonance imaging burden of cerebral small vessel disease. Front Neurol 2018;9:221 doi:10.3389/fneur.2018.00221 pmid:29681883

    CrossRefPubMed
13. 13.↵
    2. Luciano M,
    3. Marioni RE,
    4. Valdes HM, et al

    . Structural brain MRI trait polygenic score prediction of cognitive abilities. Twin Res Hum Genet 2015;18:738–45 doi:10.1017/thg.2015.71 pmid:26427786

    CrossRefPubMed
14. 14.↵
    2. Habes M,
    3. Erus G,
    4. Toledo JB, et al

    . White matter hyperintensities and imaging patterns of brain ageing in the general population. Brain 2016;139:1164–79 doi:10.1093/brain/aww008 pmid:26912649

    CrossRefPubMed
15. 15.↵
    2. Maki T,
    3. Hayakawa K,
    4. Pham LD, et al

    . Biphasic mechanisms of neurovascular unit injury and protection in CNS diseases. CNS Neurol Disord Drug Targets 2013;12:302–15 doi:10.2174/1871527311312030004 pmid:23469847

    CrossRefPubMed
16. 16.↵
    2. Lo EH,
    3. Rosenberg GA

    . The neurovascular unit in health and disease: introduction. Stroke 2009;40:S2–3 doi:10.1161/STROKEAHA.108.534404 pmid:19064779

    FREE Full Text
17. 17.↵
    2. Debette S,
    3. Markus HS

    . The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ 2010;341:c3666 doi:10.1136/bmj.c366]6 pmid:20660506

    Abstract/FREE Full Text
18. 18.↵
    2. Jagust W

    . Vulnerable neural systems and the borderland of brain aging and neurodegeneration. Neuron 2013;77:219–34 doi:10.1016/j.neuron.2013.01.002 pmid:23352159

    CrossRefPubMed
19. 19.↵
    2. Fornage M,
    3. Debette S,
    4. Bis JC, et al

    . Genome-wide association studies of cerebral white matter lesion burden: the charge consortium. Ann Neurol 2011;69:928–39 doi:10.1002/ana.22403 pmid:21681796

    CrossRefPubMedWeb of Science
20. 20.↵
    2. Turner ST,
    3. Jack CR,
    4. Fornage M, et al

    . Heritability of leukoaraiosis in hypertensive sibships. Hypertension 2004;43:483–87 doi:10.1161/01.HYP.0000112303.26158.92 pmid:14718359

    CrossRefPubMed
21. 21.↵
    2. Verhaaren BF,
    3. Debette S,
    4. Bis JC, et al

    . Multiethnic genome-wide association study of cerebral white matter hyperintensities on MRI. Circ Cardiovasc Genet 2015;8:398–409 doi:10.1161/CIRCGENETICS.114.000858 pmid:25663218

    Abstract/FREE Full Text
22. 22.↵
    2. Raina A,
    3. Zhao X,
    4. Grove ML, et al

    . Cerebral white matter hyperintensities on MRI and acceleration of epigenetic aging: the Atherosclerosis Risk in Communities Study. Clin Epigenetics 2017;9:21 doi:10.1186/s13148-016-0302-6 pmid:28289478

    CrossRefPubMed
23. 23.↵
    2. Silbert LC,
    3. Lahna D,
    4. Promjunyakul NO, et al

    . Risk factors associated with cortical thickness and white matter hyperintensities in dementia free Okinawan elderly. J Alzheimers Dis 2018;63:365–72 doi:10.3233/JAD-171153 pmid:29578488

    CrossRefPubMed
24. 24.↵
    2. Walker KA,
    3. Power MC,
    4. Hoogeveen RC, et al

    . Midlife systemic inflammation, late-life white matter integrity, and cerebral small vessel disease: the Atherosclerosis Risk in Communities Study. Stroke 2017;48:3196–3202 doi:10.1161/STROKEAHA.117.018675 pmid:29101255

    Abstract/FREE Full Text
25. 25.↵
    2. Nam KW,
    3. Kwon HM,
    4. Jeong HY, et al

    . High neutrophil to lymphocyte ratio is associated with white matter hyperintensity in a healthy population. J Neurol Sci 2017;380:128–31 doi:10.1016/j.jns.2017.07.024 pmid:28870552

    CrossRefPubMed
26. 26.↵
    2. Wong SM,
    3. Jansen JF,
    4. Zhang CE, et al

    . Blood-brain barrier impairment and hypoperfusion are linked in cerebral small vessel disease. Neurology 2019;92:e1669–77 doi:10.1212/WNL.0000000000007263 pmid:30867275

    Abstract/FREE Full Text
27. 27.↵
    2. Markus HS,
    3. Lythgoe DJ,
    4. Ostegaard L, et al

    . Reduced cerebral blood flow in white matter in ischaemic leukoaraiosis demonstrated using quantitative exogenous contrast-based perfusion MRI. J Neurol Neurosurg Psychiatry 2000;69:48–53 doi:10.1136/jnnp.69.1.48 pmid:10864603

    Abstract/FREE Full Text
28. 28.↵
    2. Arba F,
    3. Leigh R,
    4. Inzitari D, et al

    . Blood-brain barrier leakage increases with small vessel disease in acute ischemic stroke. Neurology 2017;89:2143–50 doi:10.1212/WNL.0000000000004677 pmid:29070665

    Abstract/FREE Full Text
29. 29.↵
    2. Gupta N,
    3. Simpkins AN,
    4. Hitomi E, et al

    . White matter hyperintensity-associated blood-brain barrier disruption and vascular risk factors. J Stroke Cerebrovasc Dis 2018;27:466–71 doi:10.1016/j.jstrokecerebrovasdis.2017.09.026 pmid:29100854

    CrossRefPubMed
30. 30.↵
    2. Schumann P,
    3. Touzani O,
    4. Young AR, et al

    . Evaluation of the ratio of cerebral blood flow to cerebral blood volume as an index of local cerebral perfusion pressure. Brain 1998;121:1369–79 doi:10.1093/brain/121.7.1369 pmid:9679787

    CrossRefPubMedWeb of Science
31. 31.↵
    2. Shi Y,
    3. Thrippleton MJ,
    4. Makin SD, et al

    . Cerebral blood flow in small vessel disease: a systematic review and meta-analysis. J Cereb Blood Flow Metab 2016;36:1653–67 doi:10.1177/0271678X16662891 pmid:27496552

    CrossRefPubMed
32. 32.↵
    2. Zaharchuk G

    . Theoretical basis of hemodynamic MR imaging techniques to measure cerebral blood volume, cerebral blood flow, and permeability. AJNR Am J Neuroradiol 2007;28:1850–58 doi:10.3174/ajnr.A0831 pmid:17998415

    CrossRefPubMed
33. 33.↵
    2. Patlak CS,
    3. Blasberg RG,
    4. Fenstermacher JD

    . Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab 1983;3:1–7 doi:10.1038/jcbfm.1983.1 pmid:6822610

    CrossRefPubMedWeb of Science
34. 34.↵
    2. Brickman AM,
    3. Zahra A,
    4. Muraskin J, et al

    . Reduction in cerebral blood flow in areas appearing as white matter hyperintensities on magnetic resonance imaging. Psychiatry Res 2009;172:117–20 doi:10.1016/j.pscychresns.2008.11.006 pmid:19324534

    CrossRefPubMedWeb of Science
35. 35.↵
    2. Sachdev P,
    3. Wen W,
    4. Shnier R, et al

    . Cerebral blood volume in T2-weighted white matter hyperintensities using exogenous contrast-based perfusion MRI. J Neuropsychiatry Clin Neurosci 2004;16:83–92 doi:10.1176/appi.neuropsych.16.1.83 pmid:14990763

    CrossRefPubMed
36. 36.↵
    2. Knutsson L,
    3. Stahlberg F,
    4. Wirestam R

    . Absolute quantification of perfusion using dynamic susceptibility contrast MRI: pitfalls and possibilities. MAGMA 2010;23:1–21 doi:10.1007/s10334-009-0190-2 pmid:19960361

    CrossRefPubMed
37. 37.↵
    2. Nyquist PA,
    3. Bilgel M,
    4. Gottesman R, et al

    . Age differences in periventricular and deep white matter lesions. Neurobiol Aging 2015;36:1653–58 doi:10.1016/j.neurobiolaging.2015.01.005 pmid:25659858

    CrossRefPubMed
38. 38.↵
    2. Nyquist PA,
    3. Yanek LR,
    4. Bilgel M, et al

    . Effect of white matter lesions on manual dexterity in healthy middle-aged persons. Neurology 2015;84:1920–26 doi:10.1212/WNL.0000000000001557 pmid:25862800

    CrossRefPubMed
39. 39.↵
    2. Nyquist PA,
    3. Yanek LR,
    4. Kral BG, et al

    . White matter lesion progression and cognitive function over 5 years in a young susceptible population. Neuroepidemiology 2017;49:62–63 doi:10.1159/000480238 pmid:28850949

    CrossRefPubMed
40. 40.↵
    2. Roy S,
    3. He Q,
    4. Sweeney E, et al

    . Subject-specific sparse dictionary learning for atlas-based brain MRI segmentation. IEEE J Biomed Health Inform 2015;19:1598–1609 doi:10.1109/JBHI.2015.2439242 pmid:26340685

    CrossRefPubMed
41. 41.↵
    2. Roy S,
    3. Carass A,
    4. Prince JL, et al

    . Subject-specific sparse dictionary learning for atlas based brain MRI segmentation. Mach Learning Med Imaging 2014;8679:248–55 doi:10.1007/978-3-319-10581-9_31 pmid:25383394

    CrossRefPubMed
42. 42.↵
    2. O'Sullivan M,
    3. Lythgoe DJ,
    4. Pereira AC, et al

    . Patterns of cerebral blood flow reduction in patients with ischemic leukoaraiosis. Neurology 2002;59:321–26 doi:10.1212/WNL.59.3.321 pmid:12177363

    Abstract/FREE Full Text
43. 43.↵
    2. Becker DM,
    3. Yook RM,
    4. Moy TF, et al

    . Markedly high prevalence of coronary risk factors in apparently healthy African-American and White siblings of persons with premature coronary heart disease. Am J Cardiol 1998;82:1046–51 doi:10.1016/S0002-9149(98)00553-0 pmid:9817479

    CrossRefPubMedWeb of Science
44. 44.↵
    2. Nyquist PA,
    3. Wityk R,
    4. Yanek LR, et al

    . Silent small-vessel cerebrovascular disease and silent myocardial ischemia in families with premature coronary disease. Neuroepidemiology 2009;33:66–67 doi:10.1159/000215831 pmid:19407462

    CrossRefPubMed
45. 45.↵
    2. Shiee N,
    3. Bazin PL,
    4. Ozturk A, et al

    . A topology-preserving approach to the segmentation of brain images with multiple sclerosis lesions. Neuroimage 2010;49:1524–35 doi:10.1016/j.neuroimage.2009.09.005 pmid:19766196

    CrossRefPubMed
46. 46.↵
    2. Sourbron SP,
    3. Buckley DL

    . On the scope and interpretation of the Tofts models for DCE-MRI. Magn Reson Med 2011;66:735–45 doi:10.1002/mrm.22861 pmid:21384424

    CrossRefPubMed
47. 47.↵
    2. Wu O,
    3. Østergaard L,
    4. Weisskoff RM, et al

    . Tracer arrival timing-insensitive technique for estimating flow in MR perfusion-weighted imaging using singular value decomposition with a block-circulant deconvolution matrix. Magn Reson Med 2003;50:164–74 doi:10.1002/mrm.10522 pmid:12815691

    CrossRefPubMedWeb of Science
48. 48.↵
    2. Dewey B

    . ECTRIMS ONLINE LIBRARY. 2017. https://www.ectrims.eu/online-library/. Accessed March 1, 2020
49. 49.↵
    2. Avants BB,
    3. Tustison NJ,
    4. Song G, et al

    . A reproducible evaluation of ANTS similarity metric performance in brain image registration. Neuroimage 2011;54:2033–44 doi:10.1016/j.neuroimage.2010.09.025 pmid:20851191

    CrossRefPubMed
50. 50.↵
    2. Roy S,
    3. Butman JA,
    4. Pham DL

    . Robust skull stripping using multiple MR image contrasts insensitive to pathology. Neuroimage 2017;146:132–47 doi:10.1016/j.neuroimage.2016.11.017 pmid:27864083

    CrossRefPubMed
51. 51.↵
    2. Huo Y,
    3. Plassard AJ,
    4. Carass A, et al

    . Consistent cortical reconstruction and multi-atlas brain segmentation. Neuroimage 2016;138:197–210 doi:10.1016/j.neuroimage.2016.05.030 pmid:27184203

    CrossRefPubMed
52. 52.↵
    2. Leigh R,
    3. Jen SS,
    4. Varma DD, et al

    . Arrival time correction for dynamic susceptibility contrast MR permeability imaging in stroke patients. PLoS.One 2012;7:e52656 doi:10.1371/journal.pone.0052656 pmid:23285132

    CrossRefPubMed
53. 53.↵
    2. Boxerman JL,
    3. Schmainda KM,
    4. Weisskoff RM

    . Relative cerebral blood volume maps corrected for contrast agent extravasation significantly correlate with glioma tumor grade, whereas uncorrected maps do not. AJNR Am J Neuroradiol 2006;27:859–67 pmid:16611779

    PubMedWeb of Science
54. 54.↵
    2. Oishi K,
    3. Faria A,
    4. Jiang H, et al

    . Atlas-based whole brain white matter analysis using large deformation diffeomorphic metric mapping: application to normal elderly and Alzheimer's disease participants. Neuroimage 2009;46:486–99 doi:10.1016/j.neuroimage.2009.01.002 pmid:19385016

    CrossRefPubMedWeb of Science
55. 55.↵
    2. R Core Team

    . R: A Language and Environment for Statistical Computing. https://cran.r-project.org/doc/manuals/r-release/fullrefman.pdf. Accessed March 1, 2020
56. 56.↵
    2. Marstrand JR,
    3. Garde E,
    4. Rostrup E, et al

    . Cerebral perfusion and cerebrovascular reactivity are reduced in white matter hyperintensities. Stroke 2002;33:972–76 doi:10.1161/01.STR.0000012808.81667.4B pmid:11935046

    Abstract/FREE Full Text
57. 57.↵
    2. Perkio J,
    3. Aronen HJ,
    4. Kangasmaki A, et al

    . Evaluation of four postprocessing methods for determination of cerebral blood volume and mean transit time by dynamic susceptibility contrast imaging. Magn Reson Med 2002;47:973–81 doi:10.1002/mrm.10126 pmid:11979577

    CrossRefPubMedWeb of Science
58. 58.↵
    2. Mazziotta J,
    3. Toga A,
    4. Evans A, et al

    . A probabilistic atlas and reference system for the human brain: International Consortium for Brain Mapping (ICBM). Philos Trans R Soc Lond B Biol Sci 2001;356:1293–22 doi:10.1098/rstb.2001.0915 pmid:11545704

    CrossRefPubMedWeb of Science
59. 59.↵
    2. Bazin PL,
    3. Cuzzocreo JL,
    4. Yassa MA, et al

    . Volumetric neuroimage analysis extensions for the MIPAV Software Package. J Neurosci Methods 2007;165:111–21 doi:10.1016/j.jneumeth.2007.05.024 pmid:17604116

    CrossRefPubMedWeb of Science
60. 60.↵
    2. Zierler KL

    . Equations for measuring blood flow by external monitoring of radioisotopes. Circ Res 1965;16:309–21 doi:10.1161/01.RES.16.4.309 pmid:14270567

    Abstract/FREE Full Text
61. 61.↵
    2. Rempp KA,
    3. Brix G,
    4. Wenz F, et al

    . Quantification of regional cerebral blood flow and volume with dynamic susceptibility contrast-enhanced MR imaging. Radiology 1994;193:637–41 doi:10.1148/radiology.193.3.7972800 pmid:7972800

    CrossRefPubMedWeb of Science
62. 62.↵
    2. Promjunyakul NO,
    3. Lahna DL,
    4. Kaye JA, et al

    . Comparison of cerebral blood flow and structural penumbras in relation to white matter hyperintensities: a multi-modal magnetic resonance imaging study. J Cereb Blood Flow Metab 2016;36:1528–36 doi:10.1177/0271678X16651268 pmid:27270266

    CrossRefPubMed
63. 63.↵
    2. van Osch MJ,
    3. Teeuwisse WM,
    4. van Walderveen MA, et al

    . Can arterial spin-labeling detect white matter perfusion signal? Magn Reson Med 2009;62:165–73 doi:10.1002/mrm.22002 pmid:19365865

    CrossRefPubMed
64. 64.↵
    2. Welker K,
    3. Boxerman J,
    4. Kalnin A, et al

    . ASFNR recommendations for clinical performance of MR dynamic susceptibility contrast perfusion imaging of the brain. AJNR Am J Neuroradiol 2015;36:E41–51 doi:10.3174/ajnr.A4341 pmid:25907520

    Abstract/FREE Full Text
65. 65.↵
    2. Barnes SR,
    3. Ng TS,
    4. Montagne A, et al

    . Optimal acquisition and modeling parameters for accurate assessment of low K^trans blood-brain barrier permeability using dynamic contrast-enhanced MRI. Magn Reson Med 2016;75:1967–77 doi:10.1002/mrm.25793 pmid:26077645

    CrossRefPubMed